Goals for precision medicine in NSCLC
Silvia Novello, MD, PhD, of San Luigi Gonzaga University Hospital, Orbassano, Italy, discusses precision medicine at the European Lung Cancer Congress (ELCC) 2018, held in Geneva, Switzerland. She exp...
Author: VJOncology
Added: 09/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 4, 2018 Category: Cancer & Oncology Source Type: podcasts
The reality of implementing TKI therapies for NSCLC in Europe
Speaking from the European Lung Cancer Congress (ELCC) 2018, held in Geneva, Switzerland, Silvia Novello, MD, PhD, of San Luigi Gonzaga University Hospital, Orbassano, Italy, discusses the logistical ...
Author: VJOncology
Added: 08/31/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 31, 2018 Category: Cancer & Oncology Source Type: podcasts
Therapy sequencing in the current NSCLC treatment landscape
In this video, recorded at the European Lung Cancer Congress (ELCC) 2018, held in Geneva, Switzerland, Nicolas Girard, MD, PhD, of Claude Bernard University, Lyon, France, discusses treatment sequenci...
Author: VJOncology
Added: 08/31/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 31, 2018 Category: Cancer & Oncology Source Type: podcasts
Optimizing treatment of ALK+ NSCLC: clinical realities
In this video, recorded at the European Lung Cancer Congress (ELCC) 2018, held in Geneva, Switzerland, Silvia Novello, MD, PhD, of San Luigi Gonzaga University Hospital, Orbassano, Italy, discusses ho...
Author: VJOncology
Added: 08/31/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 31, 2018 Category: Cancer & Oncology Source Type: podcasts
The need for RCTs in immunotherapy for mesothelioma
Speaking from the 2018 European Lung Cancer Congress (ELCC) in Geneva, Switzerland, Dean Fennell, PhD, FRCP, of the University of Leicester, Leicester, UK, stresses the need for increased randomized c...
Author: VJOncology
Added: 08/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 29, 2018 Category: Cancer & Oncology Source Type: podcasts
Lung cancer today: screening, surgery & amp; radiotherapy
Speaking from the European Lung Cancer Congress (ELCC) 2018, held in Geneva, Switzerland, Matti Aapro, MD, of the Clinique de Genolier, Genolier, Switzerland, discusses the hot topics in lung cancer t...
Author: VJOncology
Added: 08/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 29, 2018 Category: Cancer & Oncology Source Type: podcasts
Increasing cigarette price as a lung cancer prevention incentive
Decreasing tobacco intake is a key goal for reducing the incidence of lung cancer. In this video, recorded at the European Lung Cancer Congress (ELCC) 2018, held in Geneva, Switzerland, Matti Aapro, M...
Author: VJOncology
Added: 08/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 29, 2018 Category: Cancer & Oncology Source Type: podcasts
Immunotherapy in NSCLC: a perspective
Speaking from the European Lung Cancer Congress (ELCC) 2018, held in Geneva, Switzerland, Giorgio Scagliotti, MD, PhD, from the University of Turin, Turin, Italy, provides an overview of recent trial ...
Author: VJOncology
Added: 08/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 29, 2018 Category: Cancer & Oncology Source Type: podcasts
Increased survival in NSCLC: new considerations
Speaking from the 2018 European Lung Cancer Congress (ELCC) in Geneva, Switzerland, Federico Capuzzo, MD, PhD, of AUSL della Romagna, Ravenna, Italy, talks about how overall survival has improved in p...
Author: VJOncology
Added: 08/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 29, 2018 Category: Cancer & Oncology Source Type: podcasts
The role of the pathologist in the field of lung cancer
Speaking from the European Lung Cancer Congress (ELCC) 2018, held in Geneva, Switzerland, Keith Kerr, MB, ChB, FRCPath, FRCPE, from the University of Aberdeen, Aberdeen, UK, describes the increasing c...
Author: VJOncology
Added: 08/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 29, 2018 Category: Cancer & Oncology Source Type: podcasts
Obinutuzumab/chlorambucil gives OS benefit over rituximab in frontline CLL
Exciting updates on obinutuzumab were presented at the 23rd congress of the European Hematology Association (EHA) 2018, held in Stockholm, Sweden. Final analysis results from the CLL11 study (NCT01010...
Author: VJHemOnc
Added: 08/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 15, 2018 Category: Cancer & Oncology Source Type: podcasts
Meletios Exciting new therapy for Waldenstrms macroglobulinemia: ibrutinib plus rituximab
Data from the exciting iNNOVATE study (NCT02165397) of ibrutinib plus rituximab for patients with Waldenstrms macroglobulinemia (WM) were presented at the 23rd congress of the European Hematology As...
Author: VJHemOnc
Added: 08/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 15, 2018 Category: Cancer & Oncology Source Type: podcasts
Exciting new therapy for Waldenstrms macroglobulinemia: ibrutinib plus rituximab
Data from the exciting iNNOVATE study (NCT02165397) of ibrutinib plus rituximab for patients with Waldenstrms macroglobulinemia (WM) were presented at the 23rd congress of the European Hematology As...
Author: VJHemOnc
Added: 08/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 15, 2018 Category: Cancer & Oncology Source Type: podcasts
Making CAR T-cells happen in Europe
John Gribben, of Barts Cancer Institute, London, UK, discusses making CAR T-cells happen in Europe. This video was recorded at the 23rd congress of the European Hematology Association (EHA) 2018 press...
Author: VJHemOnc
Added: 08/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 15, 2018 Category: Cancer & Oncology Source Type: podcasts
Update on bb2121 CAR T-cell product for MM from EHA 2018
Speaking from the 23rd congress of the European Hematology Association (EHA) 2018 press briefing, held in Stockholm, Sweden, Dr Jess Berdeja of the Sarah Cannon Research Institute and Tennessee Oncol...
Author: VJHemOnc
Added: 08/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 15, 2018 Category: Cancer & Oncology Source Type: podcasts